Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JIENING aspirin enteric sustained-release tablets efficacy and pharmacoeconomic evaluation
ChiCTR1800018517Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in cardiac morbidity and coronary arteriosclerosis (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Arachidonic acid-induced platelet aggregation at Day 14. Started Sep 2016; status: completed.
02
Drugs
aspirin
03
Conditions
cardiac morbiditycoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800018517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018517.